Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune... by Pinckney, Ashley, MS, Rigby, Mark R., MD, PhD, Keyes-Elstein, Lynette, DrPH, Soppe, Carol L., MS, Nepom, Gerald T., MD, PhD, Ehlers, Mario R., MBChB, PhD

Get full text

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients by Rigby, Mark R, Harris, Kristina M, Pinckney, Ashley, DiMeglio, Linda A, Rendell, Marc S, Felner, Eric I, Dostou, Jean M, Gitelman, Stephen E, Griffin, Kurt J, Tsalikian, Eva, Gottlieb, Peter A, Greenbaum, Carla J, Sherry, Nicole A, Moore, Wayne V, Monzavi, Roshanak, Willi, Steven M, Raskin, Philip, Keyes-Elstein, Lynette, Long, S Alice, Kanaparthi, Sai, Lim, Noha, Phippard, Deborah, Soppe, Carol L, Fitzgibbon, Margret L, McNamara, James, Nepom, Gerald T, Ehlers, Mario R

Get full text

IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes by Greenbaum, Carla J, Serti, Elisavet, Lambert, Katharina, Weiner, Lia J, Kanaparthi, Sai, Lord, Sandra, Gitelman, Stephen E, Wilson, Darrell M, Gaglia, Jason L, Griffin, Kurt J, Russell, William E, Raskin, Philip, Moran, Antoinette, Willi, Steven M, Tsalikian, Eva, DiMeglio, Linda A, Herold, Kevan C, Moore, Wayne V, Goland, Robin, Harris, Mark, Craig, Maria E, Schatz, Desmond A, Baidal, David A, Rodriguez, Henry, Utzschneider, Kristina M, Nel, Hendrik J, Soppe, Carol L, Boyle, Karen D, Cerosaletti, Karen, Keyes-Elstein, Lynette, Long, S Alice, Thomas, Ranjeny, McNamara, James G, Buckner, Jane H, Sanda, Srinath

Get full text

Correlation Between Hypoglycemia, Glycemic Variability and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes: Analysis of Data from the ITN T1DAL Tria... by Pinckney, Ashley, Rigby, Mark R., Keyes-Elstein, Lynette, Soppe, Carol L., Nepom, Gerald T., Ehlers, Mario R.

Get full text

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients by Rigby, Mark R, Harris, Kristina M, Pinckney, Ashley, DiMeglio, Linda A, Rendell, Marc S, Felner, Eric I, Dostou, Jean M, Gitelman, Stephen E, Griffin, Kurt J, Tsalikian, Eva, Gottlieb, Peter A, Greenbaum, Carla J, Sherry, Nicole A, Moore, Wayne V, Monzavi, Roshanak, Willi, Steven M, Raskin, Philip, Keyes-Elstein, Lynette, Long, S. Alice, Kanaparthi, Sai, Lim, Noha, Phippard, Deborah, Soppe, Carol L, Fitzgibbon, Margret L, McNamara, James, Nepom, Gerald T, Ehlers, Mario R

Get full text

2. Durable Efficacy of Alefacept in New-Onset Type 1 Diabetes: Evidence for Lasting Modulation of Effector and Regulatory T Cells (231-OR) by Rigby, Mark R., Harris, Kristina M., Pinckney, Ashley, Dimeglio, Linda A., Rendell, Marc S., Felner, Eric I., Dostou, Jean M., Gitelman, Stephen E., Tsalikian, Eva, Griffin, Kurt J., Gottlieb, Peter A., Greenbaum, Carla J., Sherry, Nicole A., Moore, Wayne V., Monzavi, Roshanak, Willi, Steven M., Raskin, Philip, Keyes-Elstein, Lynette, Long, Sarah A., Kanaparthi, Sai, Lim, Noha, Phippard, Deborah, Soppe, Carol L., Fitzgibbon, Margret L., Mcnamara, James, Nepom, Gerald T., Ehlers, Mario R.

Get full text